Addendum: Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis

Michael Jonathan Kucharczyk; Andrew Bang; Michael C. Tjong; Stefania Papatheodorou; Jesus C. Fabregas

doi:10.18632/oncotarget.28484

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Addendum:

Addendum: Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis

PDF | How to cite

Oncotarget. 2023; 14:778-778. https://doi.org/10.18632/oncotarget.28484

Metrics: PDF 492 views | ?

Michael Jonathan Kucharczyk^1,2, Andrew Bang³, Michael C. Tjong⁴, Stefania Papatheodorou⁵, and Jesus C. Fabregas⁶

¹Department of Radiation Oncology, Nova Scotia Cancer Centre, Halifax, NS B3H 1V7, Canada
²Department of Radiation Oncology, Dalhousie University, Halifax, NS B3H 1V7, Canada
³Department of Surgery, BC Cancer – Vancouver, Vancouver, BC V5Z 4E6, Canada
⁴Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON M5T 1W6, Canada
⁵Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
⁶Department of Medicine, University of Florida Health Cancer Center, Gainesville, FL 32610, USA

Published: August 30, 2023

Copyright: © 2023 Kucharczyk et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: No external funding was obtained.

Original article: Oncotarget. 2022; 13:1109-1119. DOI: https://doi.org/10.18632/oncotarget.28280.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28484

Publication Alerts

Post-Publication Promotion

Addendum:

Addendum: Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis